ARKG vs XLV
ARK Genomic Revolution ETF vs Health Care Select Sector SPDR Fund
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
XLV—
Health Care Select Sector SPDR Fund
S&P 500 health care sector.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | State Street |
ARKG top holdings
Holdings data unavailable for ARKG.
XLV top holdings
Holdings data unavailable for XLV.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector.